questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzopyranes
Coumarines
4-Hydroxycoumarines
Phenprocoumone
Phenprocoumone : Questions médicales fréquentes
Diagnostic
5
Tests de coagulation
Fonction hépatique
INR
Efficacité thérapeutique
Symptômes
Urgence médicale
Symptômes
5
Effets secondaires
Saignement
Réaction allergique
Eruptions cutanées
Douleurs abdominales
Effets secondaires
Prévention
5
Régime alimentaire
Vitamine K
Interactions médicamenteuses
Consultation médicale
Examens réguliers
Tests de coagulation
Traitements
5
Administration orale
Comprimés
Interactions médicamenteuses
Antibiotiques
Durée du traitement
Indications thérapeutiques
Complications
5
Facteurs de risque
Anticoagulants
Signes d'alerte
Saignement
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phenprocoumone : Questions médicales les plus fréquentes",
"headline": "Phenprocoumone : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phenprocoumone : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2026-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phenprocoumone"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "4-Hydroxycoumarines",
"url": "https://questionsmedicales.fr/mesh/D015110",
"about": {
"@type": "MedicalCondition",
"name": "4-Hydroxycoumarines",
"code": {
"@type": "MedicalCode",
"code": "D015110",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Phenprocoumone",
"alternateName": "Phenprocoumon",
"code": {
"@type": "MedicalCode",
"code": "D010644",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joachim Hoyer",
"url": "https://questionsmedicales.fr/author/Joachim%20Hoyer",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, University Hospital of Marburg, UKGM GmbH, Baldingerstraße 1, 35033, Marburg, Germany. hoyer@med.uni-marburg.de."
}
},
{
"@type": "Person",
"name": "Jasper H A van Miert",
"url": "https://questionsmedicales.fr/author/Jasper%20H%20A%20van%20Miert",
"affiliation": {
"@type": "Organization",
"name": "Martini Ziekenhuis, afd. Interne Geneeskunde, Groningen."
}
},
{
"@type": "Person",
"name": "Margriet Piersma-Wichers",
"url": "https://questionsmedicales.fr/author/Margriet%20Piersma-Wichers",
"affiliation": {
"@type": "Organization",
"name": "UMC Groningen, afd. Hematologie, Groningen."
}
},
{
"@type": "Person",
"name": "Karina Meijer",
"url": "https://questionsmedicales.fr/author/Karina%20Meijer",
"affiliation": {
"@type": "Organization",
"name": "UMC Groningen, afd. Hematologie, Groningen."
}
},
{
"@type": "Person",
"name": "Christopher Hohmann",
"url": "https://questionsmedicales.fr/author/Christopher%20Hohmann",
"affiliation": {
"@type": "Organization",
"name": "Department III of Internal Medicine, Heart Center, University Hospital of Cologne, Cologne, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Bleeding Complications in a Patient After the Unexpected Interaction between Valproic Acid and Phenprocoumon.",
"datePublished": "2024-00-00",
"url": "https://questionsmedicales.fr/article/36896908",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/1574886318666230310104322"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of excessive consumption of liquorice on phenprocoumon (Marcumar®): a case report.",
"datePublished": "2021-Nov-00",
"url": "https://questionsmedicales.fr/article/34826377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03000605211049649"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vitamin K Antagonist (Phenprocoumon) and Subarachnoid Hemorrhage: A Single-Center, Matched-Pair Analysis.",
"datePublished": "2020-08-00",
"url": "https://questionsmedicales.fr/article/31659679",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12028-019-00868-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Shorter hospital stays in epistaxis patients with atrial fibrillation when taking rivaroxaban or apixaban versus phenprocoumon.",
"datePublished": "2019-Apr-00",
"url": "https://questionsmedicales.fr/article/30729376",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11239-019-01824-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits.",
"datePublished": "2019-May-01",
"url": "https://questionsmedicales.fr/article/30649301",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/europace/euy308"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzopyranes",
"item": "https://questionsmedicales.fr/mesh/D001578"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coumarines",
"item": "https://questionsmedicales.fr/mesh/D003374"
},
{
"@type": "ListItem",
"position": 7,
"name": "4-Hydroxycoumarines",
"item": "https://questionsmedicales.fr/mesh/D015110"
},
{
"@type": "ListItem",
"position": 8,
"name": "Phenprocoumone",
"item": "https://questionsmedicales.fr/mesh/D010644"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phenprocoumone - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phenprocoumone",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phenprocoumone",
"description": "Comment diagnostiquer une surdose de phenprocoumone ?\nQuels tests sont nécessaires avant de commencer le phenprocoumone ?\nQuels signes indiquent une complication liée au phenprocoumone ?\nComment évaluer l'efficacité du phenprocoumone ?\nQuels symptômes nécessitent un contrôle médical urgent ?",
"url": "https://questionsmedicales.fr/mesh/D010644#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phenprocoumone",
"description": "Quels sont les effets secondaires courants du phenprocoumone ?\nComment reconnaître une réaction allergique au phenprocoumone ?\nQuels signes d'hémorragie doivent alerter ?\nLe phenprocoumone peut-il causer des douleurs abdominales ?\nQuels symptômes indiquent une thrombose malgré le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D010644#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phenprocoumone",
"description": "Comment prévenir les complications du phenprocoumone ?\nQuelles précautions prendre lors de la prise de phenprocoumone ?\nLe régime alimentaire influence-t-il le phenprocoumone ?\nComment éviter les interactions médicamenteuses ?\nQuels examens réguliers sont nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D010644#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phenprocoumone",
"description": "Comment le phenprocoumone est-il administré ?\nQuelles sont les alternatives au phenprocoumone ?\nComment ajuster la dose de phenprocoumone ?\nQuels médicaments interagissent avec le phenprocoumone ?\nQuelle est la durée du traitement par phenprocoumone ?",
"url": "https://questionsmedicales.fr/mesh/D010644#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phenprocoumone",
"description": "Quelles sont les complications possibles du phenprocoumone ?\nComment gérer une hémorragie due au phenprocoumone ?\nQuels facteurs augmentent le risque de complications ?\nComment reconnaître une thrombose malgré le traitement ?\nQuels signes d'alerte doivent être surveillés ?",
"url": "https://questionsmedicales.fr/mesh/D010644#section-complications"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surdose de phenprocoumone ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de coagulation, comme l'INR, est utilisé pour diagnostiquer une surdose."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant de commencer le phenprocoumone ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de coagulation et une évaluation de la fonction hépatique sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication liée au phenprocoumone ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements inhabituels ou des ecchymoses peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du phenprocoumone ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par le suivi régulier de l'INR du patient."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un contrôle médical urgent ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des maux de tête sévères ou des saignements doivent être évalués."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants du phenprocoumone ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des saignements, des nausées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique au phenprocoumone ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Quels signes d'hémorragie doivent alerter ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements des gencives, des urines rouges ou des selles noires sont alarmants."
}
},
{
"@type": "Question",
"name": "Le phenprocoumone peut-il causer des douleurs abdominales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent survenir comme effet secondaire du traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une thrombose malgré le traitement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une rougeur dans une jambe peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du phenprocoumone ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier de l'INR et une bonne observance du traitement aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de la prise de phenprocoumone ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les activités à risque de blessure et informez votre médecin de tout nouveau médicament."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire influence-t-il le phenprocoumone ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les aliments riches en vitamine K peuvent affecter l'efficacité du phenprocoumone."
}
},
{
"@type": "Question",
"name": "Comment éviter les interactions médicamenteuses ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Discutez toujours avec votre médecin avant de commencer un nouveau médicament."
}
},
{
"@type": "Question",
"name": "Quels examens réguliers sont nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de coagulation réguliers sont nécessaires pour surveiller l'effet du traitement."
}
},
{
"@type": "Question",
"name": "Comment le phenprocoumone est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le phenprocoumone est administré par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives au phenprocoumone ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent la warfarine et d'autres anticoagulants oraux."
}
},
{
"@type": "Question",
"name": "Comment ajuster la dose de phenprocoumone ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dose est ajustée en fonction des résultats de l'INR et de la réponse du patient."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec le phenprocoumone ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les antibiotiques et les anti-inflammatoires peuvent interagir."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement par phenprocoumone ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement dépend de l'indication, souvent plusieurs mois à plusieurs années."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du phenprocoumone ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des saignements graves, des thromboses et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une hémorragie due au phenprocoumone ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémorragie peut nécessiter l'administration de vitamine K ou de facteurs de coagulation."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies hépatiques et l'utilisation d'autres anticoagulants augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une thrombose malgré le traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une chaleur dans une jambe peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte doivent être surveillés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les saignements, les douleurs thoraciques et les changements de vision."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Nephrology, University Hospital of Marburg, UKGM GmbH, Baldingerstraße 1, 35033, Marburg, Germany. hoyer@med.uni-marburg.de.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
Martini Ziekenhuis, afd. Interne Geneeskunde, Groningen.
Contact: Jasper H.A. van Miert (j.vanmiert@mzh.nl).
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
UMC Groningen, afd. Hematologie, Groningen.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
UMC Groningen, afd. Hematologie, Groningen.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
Department III of Internal Medicine, Heart Center, University Hospital of Cologne, Cologne, Germany.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
Department III of Internal Medicine, Heart Center, University Hospital of Cologne, Cologne, Germany.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
Institute of General Practice, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany lisette.warkentin@uk-erlangen.de.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
GWQ ServicePlus AG, Düsseldorf, Germany.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
GWQ ServicePlus AG, Düsseldorf, Germany.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
Institute of General Practice, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Publications dans "Phenprocoumone" :
2 publications dans cette catégorie
Affiliations :
Institute of General Practice, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine Diakonessenhuis Utrecht The Netherlands.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Anesthesiology Diakonessenhuis Utrecht The Netherlands.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Anesthesiology Diakonessenhuis Utrecht The Netherlands.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Vascular Medicine University Medical Center Utrecht Utrecht The Netherlands.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine Diakonessenhuis Utrecht The Netherlands.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, University Hospital of Marburg, UKGM GmbH, Baldingerstraße 1, 35033, Marburg, Germany.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, University Hospital of Marburg, UKGM GmbH, Baldingerstraße 1, 35033, Marburg, Germany.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, University Hospital of Marburg, UKGM GmbH, Baldingerstraße 1, 35033, Marburg, Germany.
Publications dans "Phenprocoumone" :
1 publication dans cette catégorie
Affiliations :
Department of Nephrology, University Hospital of Marburg, UKGM GmbH, Baldingerstraße 1, 35033, Marburg, Germany.
Publications dans "Phenprocoumone" :
Phenprocoumon is a vitamin K antagonist that is widely prescribed in Europe and Latin America for the prophylaxis and treatment of thromboembolic events....
A 90-year-old female was admitted to our hospital with tonic-clonic seizures, possibly due to dementia syndrome. Valproic acid (VPA) was prescribed for the treatment of seizures. VPA is an inhibitor o...
When prescribing this combination, the prescriber should be warned and advised to intensify INR monitoring if the combination is to be continued....
Here, the case of a 92-year-old female patient, who was diagnosed with atrial fibrillation and treated with phenprocoumon (Marcumar®), is reported. Pre-existing comorbidities were arterial hypertensio...
Demographic changes are leading to an aging society with a growing number of patients relying on anticoagulation, and vitamin K antagonists (VKA) are still widely used. As mortality and functional out...
All patients treated for non-traumatic SAH between January 2007 and December 2016 in our institution were retrospectively analyzed. After exclusion of patients with anticoagulant or antiplatelet treat...
Patients with phenprocoumon treatment were significantly older (66.5 years vs. 53.9 years; p < .0001), and admission status was significantly more often poor (66.7% vs. 41.8%, p = .007) compared to al...
Patients with phenprocoumon treatment at the time of SAH are significantly older, admission status is worse, and 30-day mortality rates are significantly higher compared to patients without anticoagul...
Patients taking oral anticoagulants (OACs) currently represent one-third of all patients treated for epistaxis and an upward trend is expected. New direct oral anticoagulants (DOACs) have been on the ...
Bridging anticoagulation in atrial fibrillation (AF) patients who need to interrupt vitamin K antagonists for procedures is a clinical dilemma. Currently, guidelines recommend clinicians to take the s...
A model was developed to simulate both a bridge and a non-bridge cohort, using simulated international normalized ratio (INR) values for patients on warfarin, acenocoumarol, and phenprocoumon. For bot...
When deciding whether to bridge anticoagulation, clinicians should consider the patient's individual stroke and bleeding risk, while also considering the patient's post-procedural INR management. In p...
Atrial fibrillation (AF) is a risk factor for brain infarction, which can lead to epilepsy. We aimed to investigate whether treatment of AF with direct oral anticoagulants (DOACs) affects the risk of ...
We performed an active comparator, nested case-control study based on the German Pharmacoepidemiological Research Database that includes claims data from statutory health insurance providers of about ...
In patients with AF initiating oral anticoagulation, treatment with a DOAC was associated with an increased risk of epilepsy compared to the vitamin K antagonist PPC. Covert brain infarction may expla...
of key results. INR, international normalized ratio; TTR, time in therapeutic range; PTR, percentage of tests in range; HRAE, hemocompatibility-related adverse event; FFUV, first follow-up visit; GIB,...
Direct oral anticoagulants (DOACs) were introduced based on randomised controlled trials (RCTs) comparing them to vitamin-K-antagonist (VKA) warfarin. In Germany, almost exclusively phenprocoumon is u...
In a retrospective observational cohort study, claims data covering inpatient and outpatient care from 2015 to 2019 were analysed by Cox regression and propensity score matching (PSM)....
Data from a group of small-sized to medium-sized health insurance companies in Germany....
We analysed datasets of 71 961 patients with AF and first prescription of phenprocoumon (n=20 179) or DOAC in standard dose (n=51 782). Patients with reduced dose of DOACs were excluded (n=21 724)....
Outcomes were thromboembolic events, major bleeding and death during a 12-month follow-up period....
The regression analysis widely showed similarity between phenprocoumon and standard dose DOACs regarding effectiveness and safety. There were only three statistically significant differences: a lower ...
The small superiority or non-inferiority of DOACs over warfarin seen in the RCTs might not translate into relevant advantages of DOACs over phenprocoumon. To confirm the hypothesis, an RCT with phenpr...
Non-vitamin K oral anticoagulants have become the standard therapy for preventing stroke and ischemic thromboembolism in most patients with atrial fibrillation (AF). The effectiveness and safety of no...
From June 2017 through May 2022, AXADIA-AFNET 8 (Compare Apixaban and Vitamin K Antagonists in Patients With Atrial Fibrillation and End-Stage Kidney Disease), an investigator-initiated PROBE (prospec...
Thirty-nine sites randomized 97 patients (30% women; mean age 75 years; mean CHA...
In this randomized trial comparing apixaban and VKA in patients with AF on hemodialysis with long follow-up, no differences were observed in safety or efficacy outcomes. Even on oral anticoagulation, ...
URL: https://www....
gov; Unique identifier: NCT02933697....
Ferroptosis, a type of iron-dependent programmed cell death distinct from apoptosis, necroptosis, and other types of cell death, is characterized by lipid peroxidation, reactive oxygen species product...